Literature DB >> 16407700

Conventional, emerging, heredity, lifestyle, and psychosocial coronary risk factors: relationships to subclinical atherosclerosis.

Allen J Taylor1, Navin S Arora, Jody Bindeman, Saroj Bhattari, Irwin M Feuerstein, Patrick G O'malley.   

Abstract

The authors examined the relationship between calcified coronary atherosclerosis and an array of cardiovascular risk factors in sequential logistic models to determine the extent to which these markers overlap in their identification of patients at risk for developing coronary heart disease. The prevalence of coronary artery calcium using electron beam computed tomography was 19.4% in this cross-sectional study of a prospective, consecutive, screening cohort of 1999 healthy United States Army personnel (aged 39-50 years). The proportion of the total variance of coronary artery calcium explained by sequential logistic models incorporating conventional, emerging, hereditary, lifestyle, and psychosocial cardiovascular risk variables increased progressively from 9.7% to 14.5%. The best-fit logistic model for the prediction of coronary artery calcium identified age, male gender, Framingham risk score, total cholesterol, high-density lipoprotein cholesterol, triglycerides, smoking, a family history of coronary heart disease, white race, physical inactivity, and lower depression scores as significant independent correlates of coronary artery calcium. These data indicate that the explanatory power of models for atherosclerosis can be significantly improved with the use of emerging, heredity, lifestyle, and psychosocial factors. The large residual variance, however, supports the potential of atherosclerosis imaging to incrementally and independently identify coronary heart disease risk.

Entities:  

Mesh:

Year:  2006        PMID: 16407700     DOI: 10.1111/j.1520-037x.2006.04301.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  7 in total

1.  Cardiomyopathy presenting as severe fatigue in a person with chronic spinal cord injury.

Authors:  Alice Kam; Rajini Sankaran; Kempe Gowda; Gary Linassi; Rodney Li Pi Shan
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

2.  Relation of Depressive Symptoms With Coronary Artery Calcium Determined by Electron-Beam Computed Tomography (from the Rancho Bernardo Study).

Authors:  John Bellettiere; Donna Kritz-Silverstein; Gail A Laughlin; Andrea Z LaCroix; Linda K McEvoy; Elizabeth Barrett-Connor
Journal:  Am J Cardiol       Date:  2015-11-18       Impact factor: 2.778

3.  Independent association between obstructive sleep apnea and subclinical coronary artery disease.

Authors:  Dan Sorajja; Apoor S Gami; Virend K Somers; Thomas R Behrenbeck; Arturo Garcia-Touchard; Francisco Lopez-Jimenez
Journal:  Chest       Date:  2008-02-08       Impact factor: 9.410

4.  Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease.

Authors:  Jarle Jortveit; Sigrun Halvorsen; Anete Kaldal; Are Hugo Pripp; Ragna Elise S Govatsmark; Jørund Langørgen
Journal:  BMC Cardiovasc Disord       Date:  2019-03-28       Impact factor: 2.298

5.  Association of Depression with Subclinical Coronary Atherosclerosis: a Systematic Review.

Authors:  Sher Ali Khan; Usman Shahzad; Muhammad Samsoor Zarak; Junaid Channa; Inamullah Khan; Muhammad Owais Abdul Ghani
Journal:  J Cardiovasc Transl Res       Date:  2020-03-20       Impact factor: 4.132

6.  The relationship between the cardiometabolic syndrome and coronary artery calcium progression.

Authors:  Allen J Taylor; Holly Wu; Jody Bindeman; Kelly Bauer; Carole Byrd; Patrick G O'Malley; Irwin Feuerstein
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

7.  Association of depressive symptom severity with coronary artery calcium: The Dallas heart study.

Authors:  Amber Khan; Jayme Palka; Parag H Joshi; Amit Khera; E Sherwood Brown
Journal:  J Affect Disord       Date:  2020-07-18       Impact factor: 4.839

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.